Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 17, Pages 4258
Publisher
MDPI AG
Online
2022-09-01
DOI
10.3390/cancers14174258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2-AKT-TGF-β signaling axis in pancreatic cancer
- (2022) Xiuhui Shi et al. GASTROENTEROLOGY
- m 6 A demethylase ALKBH5 drives denervation‐induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling
- (2022) Yuantong Liu et al. Journal of Cachexia Sarcopenia and Muscle
- C/EBPβ promotes the expression of atrophy‐inducing factors by tumours and is a central regulator of cancer cachexia
- (2022) Hamood AlSudais et al. Journal of Cachexia Sarcopenia and Muscle
- Cannabidiol (CBD) in Cancer Management
- (2022) Kylie O’Brien Cancers
- MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review)
- (2022) Xin Li et al. Experimental and Therapeutic Medicine
- The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy
- (2022) Flavia A. Graca et al. Nature Communications
- Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis
- (2022) Audrey Loumaye et al. Cells
- Multidisciplinary approaches to cancer cachexia: current service models and future perspectives
- (2022) Vanessa C Vaughan et al. Expert Review of Anticancer Therapy
- The long noncoding RNA MALAT1 modulates adipose loss in cancer-associated cachexia by suppressing adipogenesis through PPAR-γ
- (2021) Jun Han et al. Nutrition & Metabolism
- FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
- (2021) Daria Neyroud et al. Journal of Cachexia Sarcopenia and Muscle
- Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3‐mediated muscle wasting in cancer cachexia mice
- (2021) Mengyuan Niu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia
- (2021) Roberta Sartori et al. Science Translational Medicine
- Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives
- (2021) Anastasia Kottorou et al. Translational Oncology
- An integrative transcriptome study reveals Ddit4/Redd1 as a key regulator of cancer cachexia in rodent models
- (2021) Mengyuan Niu et al. Cell Death & Disease
- Sustained Systemic Levels of IL-6 Impinge Early Muscle Growth and Induce Muscle Atrophy and Wasting in Adulthood
- (2021) Laura Pelosi et al. Cells
- Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
- (2021) J. Arends et al. ESMO Open
- Tumor necrosis factor alpha regulates myogenesis to inhibit differentiation and promote proliferation in satellite cells
- (2021) Tomohiko Shirakawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
- (2021) Lu Li et al. Frontiers in Pharmacology
- MEF2c-dependent downregulation of Myocilin mediates cancer-induced muscle wasting and associates with cachexia in cancer patients
- (2020) Sarah M Judge et al. CANCER RESEARCH
- Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation
- (2020) Nissrine Daou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Management of Cancer Cachexia: ASCO Guideline
- (2020) Eric J. Roeland et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Cachexia Induces Preferential Skeletal Muscle Myosin Loss When Combined With Denervation
- (2020) Takashi Yamada et al. Frontiers in Physiology
- MicroRNA-mRNA Co-sequencing Identifies Transcriptional and Post-transcriptional Regulatory Networks Underlying Muscle Wasting in Cancer Cachexia
- (2020) Geysson Javier Fernandez et al. Frontiers in Genetics
- SIRT1–NOX4 signaling axis regulates cancer cachexia
- (2020) Aneesha Dasgupta et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
- (2020) Rowena Suriben et al. NATURE MEDICINE
- JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia
- (2020) Scott E. Mulder et al. CANCER LETTERS
- The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia
- (2020) Daniel J. Ham et al. Nature Communications
- Cancer-induced muscle wasting requires p38beta MAPK activation of p300
- (2020) Thomas K Sin et al. CANCER RESEARCH
- GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
- (2020) Danna M. Breen et al. Cell Metabolism
- Chemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes
- (2020) Mamta Amrute‐Nayak et al. Journal of Cachexia Sarcopenia and Muscle
- IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
- (2019) Dong Liu et al. Skeletal Muscle
- First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
- (2019) Jessica J Tao et al. CLINICAL CANCER RESEARCH
- Regulation of SETD7 Methyltransferase by SENP3 Is Crucial for Sarcomere Organization and Cachexia
- (2019) Arnab Nayak et al. Cell Reports
- The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
- (2019) Viviana Moresi et al. Frontiers in Physiology
- The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
- (2019) Xiaoling Zhong et al. Journal of Cachexia Sarcopenia and Muscle
- Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy
- (2019) Juuso Paajanen et al. Clinical Lung Cancer
- Neuromuscular junctions are stable in patients with cancer cachexia
- (2019) Ines Boehm et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of the JNK/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development
- (2018) Shu-Juan Xie et al. CELL DEATH AND DIFFERENTIATION
- Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia
- (2018) Parash Parajuli et al. DEVELOPMENTAL CELL
- The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
- (2018) Vicky W.W. Tsai et al. Cell Metabolism
- LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
- (2018) Talia Golan et al. Journal of Cachexia Sarcopenia and Muscle
- Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease
- (2017) Kyle R. Bohnert et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
- (2017) Marco Segatto et al. Nature Communications
- Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia
- (2017) Ashok Narasimhan et al. Journal of Cachexia Sarcopenia and Muscle
- Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
- (2016) Rulin Sun et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment
- (2016) Yuji Miyamoto et al. CLINICAL CANCER RESEARCH
- Neuromuscular junction degeneration in muscle wasting
- (2016) Rüdiger Rudolf et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation
- (2016) Yang Quan-Jun et al. MOLECULAR CANCER THERAPEUTICS
- Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia
- (2016) G B Martinelli et al. ONCOGENE
- Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice
- (2016) Catherine E. Winbanks et al. Science Translational Medicine
- MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1−/− and Parp-2−/− mice with lung cancer cachexia
- (2015) Alba Chacon-Cabrera et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer
- (2015) Yosuke Togashi et al. CANCER LETTERS
- Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy
- (2015) Sylvie Dupré-Aucouturier et al. JOURNAL OF APPLIED PHYSIOLOGY
- Role of Activin A and Myostatin in Human Cancer Cachexia
- (2015) Audrey Loumaye et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
- (2015) Lorena Lerner et al. Journal of Cachexia Sarcopenia and Muscle
- HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy
- (2014) A. W. Beharry et al. JOURNAL OF CELL SCIENCE
- Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7
- (2014) W. A. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of chemotherapy on quality of life in patients with non-small cell lung cancer
- (2014) Eileen Mannion et al. SUPPORTIVE CARE IN CANCER
- Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
- (2013) Pura Muñoz-Cánoves et al. FEBS Journal
- MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia
- (2013) Liuping Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
- (2013) Catherine E. Winbanks et al. JOURNAL OF CELL BIOLOGY
- NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
- (2013) Wei A. He et al. JOURNAL OF CLINICAL INVESTIGATION
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- BMP signaling controls muscle mass
- (2013) Roberta Sartori et al. NATURE GENETICS
- Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway
- (2012) Miriam Hoene et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
- (2012) Andrea Bonetto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle
- (2011) Sarah M. Senf et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice
- (2011) Kate T. Murphy et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes
- (2011) Balindiwe J.N. Sishi et al. CYTOKINE
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Muscle oxidative capacity during IL-6-dependent cancer cachexia
- (2010) James P. White et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Inhibition of Atrogin-1/MAFbx Expression by Adenovirus-Delivered Small Hairpin RNAs Attenuates Muscle Atrophy in Fasting Mice
- (2010) Haolong Cong et al. HUMAN GENE THERAPY
- JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy
- (2010) Anna Raffaello et al. JOURNAL OF CELL BIOLOGY
- The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
- (2010) Ashwani Mittal et al. JOURNAL OF CELL BIOLOGY
- Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice
- (2010) Pradyut K. Paul et al. JOURNAL OF CELL BIOLOGY
- Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition
- (2010) Fabio Penna et al. PLoS One
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: Relationship to acute phase response and survival
- (2009) Ross ONCOLOGY REPORTS
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
- (2008) F Strasser et al. BRITISH JOURNAL OF CANCER
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy
- (2008) Antonio L. Serrano et al. Cell Metabolism
- The initiation factor eIF3-f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy
- (2008) Julie Lagirand-Cantaloube et al. EMBO JOURNAL
- Cancer cachexia: Developing multimodal therapy for a multidimensional problem
- (2008) K.C.H. Fearon EUROPEAN JOURNAL OF CANCER
- Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise
- (2008) P. W. Bodell et al. JOURNAL OF APPLIED PHYSIOLOGY
- Interleukin-6 and cachexia in ApcMin/+ mice
- (2007) Kristen A. Baltgalvis et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More